Efficacy of Treatment with Angiotensin II Receptor Antagonist Losartan in Patients with Isolated systolic Hypertension and Reduced Left Ventricular Systolic Function Taking Angiotensin-Converting Enzyme Inhibitor Lisinopril

被引：0
|
作者：
Vatinian, Susanna
Gurgenyan, Svetlana
Nikoghosyan, Karine
机构：
来源：
CIRCULATION | 2010年 / 122卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P876
引用
收藏
页码：E267 / E267
页数：1
相关论文
共 50 条
  • [41] Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction - a meta-analysis
    Abdulla, J
    Pogue, J
    Abildstrom, SZ
    Kober, L
    Christensen, E
    Pfeffer, MA
    Yusuf, S
    Torp-Pedersen, C
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (01) : 90 - 96
  • [42] ROLE OF BISOPROLOL ADDING TO ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR AND FUROSEMIDE COMBINATION ON THE LEFT VENTRICULAR FUNCTION IN SYSTOLIC HEART FAILURE PATIENTS
    Triastuti, Efta
    Hendrawan, Dadang
    Saifurrohman, Muhammad
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (09): : 3125 - 3130
  • [43] The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function
    Abdulla, J
    Burchardt, H
    Abildstrom, SZ
    Kober, L
    Torp-Pedersen, C
    EUROPEAN HEART JOURNAL, 2003, 24 (23) : 2116 - 2122
  • [44] Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats
    Yamamoto, M
    Fukui, M
    Shou, I
    Wang, LN
    Sekizuka, K
    Suzuki, S
    Shirato, I
    Tomino, Y
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1997, 11 (01) : 53 - 62
  • [45] ANGIOTENSIN RECEPTOR BLOCKERS VS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN HYPERTENSIVE PATIENTS WITH SYSTOLIC DYSFUNCTION AFTER MYOCARDIAL INFARCTION
    Joo, S.
    Lee, J-G.
    Beom, J. W.
    Choi, J-H.
    Kim, S-Y.
    Kim, K-S.
    Rha, S. W.
    Jeong, J-O.
    Chae, S. C.
    Choi, D-J.
    Park, J. S.
    Jeong, M. H.
    JOURNAL OF HYPERTENSION, 2019, 37 : E82 - E82
  • [46] Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension
    Bisognano, JD
    Horwitz, LD
    WESTERN JOURNAL OF MEDICINE, 1998, 168 (04): : 272 - 274
  • [47] A prospective interventional randomized study to assess efficacy of angiotensin receptor neprilysin inhibitor in right ventricular systolic dysfunction with normal left ventricular systolic function
    Mathur, R.
    Kesarwani, V.
    Lakhawat, V.
    Sarda, P.
    Baroopal, A.
    Chaoudhary, C. R.
    Hakim, A.
    Verma, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 212 - 213
  • [48] Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients
    Hasvold, L. P.
    Bodegard, J.
    Thuresson, M.
    Stalhammar, J.
    Hammar, N.
    Sundstrom, J.
    Russell, D.
    Kjeldsen, S. E.
    JOURNAL OF HUMAN HYPERTENSION, 2014, 28 (11) : 663 - 669
  • [49] Efficacy of Aliskiren for Patients with Hypertension Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin-Receptor Blockers
    Fujino, Noboru
    Araki, Tsutomu
    Yasuda, Toshihiko
    Terai, Hidenobu
    Konno, Tetsuo
    Sakata, Kenji
    Hayashi, Kenshi
    Kawashiri, Masaaki
    Ino, Hidekazu
    Yamagishi, Masakazu
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S157 - S157
  • [50] Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients
    L P Hasvold
    J Bodegård
    M Thuresson
    J Stålhammar
    N Hammar
    J Sundström
    D Russell
    S E Kjeldsen
    Journal of Human Hypertension, 2014, 28 : 663 - 669
12345